← Intercure Ltd.
| Annual Trend | FY 2016 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||
| Net Income | — | — | — | — | $44.8m |
($62.0m)
-238.24%
|
($67.8m)
-9.42%
|
($35.7m)
+47.33%
|
($36.8m)
-3.01%
|
|
| Net Income From Continuing Operations | — | — | — | — | $43.7m | ($63.5m) | ($72.8m) | ($36.8m) | ($36.8m) | |
| Changes in the fair value of financial assets through profit or loss, net | — | ($21.0m) | $37.2m | $1.9m | $172k | $661k | ($371k) | $2.1m | — | |
| Financial assets measured at fair value through profit or loss | — | — | — | — | ($47k) | ($47k) | ($202k) | — | — | |
| Profit or Loss | — | — | ($36.0m) | $7.3m | $43.7m | ($63.5m) | ($72.8m) | — | — | |
| Total Adjustments to reconcile profit (loss) | — | ($5.6m) | $43.9m | $34.6m | $15.5m | $17.5m | $18.8m | $53.3m | — | |
| Depreciation & Amortization (CF) | — | $828k | $3.3m | $7.4m | $11.7m | $13.2m | $15.4m | $17.1m | $17.1m | |
| Adjustments For Deferred Tax Of Prior Periods | — | — | — | — | ($12.8m) | — | — | — | — | |
| Deferred Income Tax | — | — | — | — | $93k | $2.2m | ($14.5m) | ($7.3m) | ($7.3m) | |
| Deferred Tax | — | — | — | — | $93k | $2.2m | ($14.5m) | ($7.3m) | ($7.3m) | |
| Adjustments For Share-Based Payments | — | — | $10.0m | $6.5m | $8.9m | $2.6m | $2.3m | — | — | |
| Share-based payment (Note 18M) | — | $68.0m | $10.0m | $6.5m | $8.9m | $2.6m | $2.3m | $2.4m | — | |
| Asset Impairment Charge | — | — | — | — | $0 | $67.7m | $0 | $0 | $0 | |
| Change In Working Capital | — | — | — | — | ($3.0m) | ($91.2m) | ($9.2m) | $18.9m | $18.9m | |
| Trade and other receivables | — | $1.1m | $1.8m | $20.9m | ($1.9m) | ($1.9m) | ($4.5m) | ($3.7m) | — | |
| Change In Receivables | — | — | — | — | $16.7m | ($88.4m) | $13.3m | $9.3m | $9.3m | |
| Changes In Account Receivables | — | — | — | — | ($18.3m) | ($23.5m) | $8.4m | $30.8m | $9.3m | |
| Change in Inventory | — | $3.0m | ($14.2m) | ($15.5m) | ($75.2m) | $34.7m | ($13.2m) | $11.0m | $15.9m | |
| Inventory and biological assets | — | $7.7m | $237k | $22.8m | ($2.6m) | ($2.6m) | ($1.4m) | ($1.3m) | — | |
| Increase in other payables | — | $1.9m | $4.3m | $9.4m | ($812k) | $4.7m | $3.9m | $2.5m | — | |
| Trade and other payables | — | ($1.7m) | ($1.9m) | ($51.1m) | $7.9m | $7.9m | $4.6m | $2.5m | — | |
| Cash flows from investing activities | ||||||||||
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | — | $1.8m | $3.2m | $6.3m | ($1.9m) | $25k | ($3.6m) | ($69k) | — | |
| Purchase of property, plant and equipment | — | ($28.1m) | ($20.8m) | ($14.0m) | ($19.7m) | $7.4m | $6.0m | $10.4m | — | |
| Adjustments For Gain Loss On Disposal Of Investments In Subsidiaries Joint Ventures And Associates | — | — | — | — | — | — | $202k | — | — | |
| Net Other Investing Changes | — | — | — | — | ($108.3m) | $10.7m | $21.7m | ($1.0m) | ($1.0m) | |
| Net Cash from Investing Activities | — | — | — | — | — | $845k | — | $939k | — | |
| Cash flows from financing activities | ||||||||||
| Proceeds From Borrowings Classified As Financing Activities | — | — | — | — | $263.5m | $62.7m | $188.4m | — | — | |
| Repayments Of Borrowings Classified As Financing Activities | — | — | — | $3.4m | $120.5m | $119.9m | $175.2m | — | — | |
| Proceeds from Debt Issuance | — | — | $665k | $75.5m | $263.5m | $62.7m | $188.4m | $10.2m | — | |
| Issuance Of Debt | — | — | — | — | $263.5m | $62.7m | $188.4m | $21.1m | $21.1m | |
| Long Term Debt Issuance | — | — | — | — | $263.5m | $62.7m | $188.4m | $21.1m | $21.1m | |
| Net Issuance Payments Of Debt | — | — | — | — | $137.7m | ($62.0m) | $7.7m | ($29.1m) | ($29.1m) | |
| Net Long Term Debt Issuance | — | — | — | — | $137.7m | ($62.0m) | $7.7m | ($29.1m) | ($29.1m) | |
| Long Term Debt Payments | — | — | — | — | ($125.7m) | ($124.7m) | ($180.7m) | ($50.3m) | ($50.3m) | |
| Repayment Of Debt | — | — | — | — | ($125.7m) | ($124.7m) | ($180.7m) | ($50.3m) | ($50.3m) | |
| Issuance Of Capital Stock | — | — | — | — | $0 | $0 | $34.0m | $1.5m | $1.5m | |
| Common Stock Issuance | — | — | — | — | $0 | $0 | $34.0m | $1.5m | $1.5m | |
| Cash Dividends Paid | — | — | — | — | $0 | $0 | $0 | $0 | $0 | |
| Beginning Cash Position | — | — | — | — | $196.2m | $232.6m | $101.1m | $78.3m | $78.3m | |
| Balance of cash and cash equivalents at beginning of year | — | $27.3m | $37.9m | $196.2m | $232.6m | $101.1m | $78.3m | $46.5m | — | |
| Increase in restricted cash | — | — | — | ($20.0m) | — | ($60k) | ($465k) | ($909k) | — | |
| Decrease in restricted cash | — | — | ($40k) | ($20.0m) | $7.4m | $4.7m | $9.1m | $212k | — | |
| Effect Of Exchange Rate Changes | — | — | — | — | $7.2m | $297k | ($39k) | ($44k) | ($44k) | |
| Additional Supplementary Disclosures | ||||||||||
| Additional Supplementary Disclosures | ||||||||||
| Total of changes in assets and liabilities | — | $2.4m | ($4.1m) | ($1.7m) | ($3.0m) | ($91.2m) | ($9.2m) | $18.9m | — | |
| Additional Financial Items | ||||||||||
| Adjustments For Current Tax Of Prior Period | — | — | — | — | — | $7.6m | $14.5m | — | — | |
| General And Administrative Expense | — | — | $8.6m | $27.2m | $36.1m | $42.6m | $53.7m | — | — | |
| Goodwill | — | $168.0m | $190.1m | $258.1m | $284.2m | $221.1m | $224.6m | ($5.6m) | $0 | |
| Payments Of Lease Liabilities Classified As Financing Activities | — | — | $576k | $2.6m | $3.9m | $4.7m | $5.5m | — | — | |
| Opening balance | — | ($5.9m) | ($36.0m) | $7.3m | $43.7m | ($63.5m) | ($72.8m) | ($36.8m) | — | |
| Loans granted (Note 12B) | — | — | ($1.6m) | ($7.3m) | ($95.2m) | ($5.2m) | ($928k) | ($545k) | — | |
| Acquisition of Subsidiaries, net of cash acquired (Note 8) | — | — | $387k | ($19.1m) | $1.6m | — | $1.1m | ($114k) | — | |
| Deconsolidation of subsidiaries, net of cash (Note 8) | — | — | — | — | — | — | $1.0m | $2.4m | — | |
| Repayment of loans granted | — | — | — | — | — | $11.3m | $14.0m | $196k | — | |
| Payments of contingent consideration | — | — | — | ($3.5m) | ($6.2m) | ($4.2m) | — | — | — | |
| Lease payments | — | ($189k) | ($576k) | ($2.6m) | ($3.9m) | ($4.7m) | ($5.5m) | ($5.0m) | — | |
| Repayment of loans from banks | — | ($174k) | — | ($3.4m) | ($120.5m) | ($119.9m) | ($175.2m) | ($45.3m) | — | |
| Repayment of loan from related party | — | ($143k) | ($13.7m) | ($3.6m) | ($1.3m) | ($76k) | — | — | — | |
| Net Change in Cash | — | ($1.7m) | $221k | ($4.5m) | $7.2m | $297k | ($39k) | ($44k) | — | |
| Gain from deconsolidation of subsidiaries | — | — | — | — | — | $4.6m | ($1.3m) | $3.3m | — | |
| Finance expenses, net | — | — | — | $9.5m | $6.8m | $19.7m | $20.1m | $16.9m | — | |
| Remeasurement of contingent consideration | — | — | — | — | ($9.6m) | $1.1m | — | — | — | |
| Gain in respect of acquisition of a subsidiary | — | ($58.8m) | — | — | — | — | ($202k) | — | — | |
| Total Adjustments of comprehensive income | — | ($8.0m) | $48.1m | $36.3m | $18.5m | $108.7m | $27.9m | $34.4m | — | |
| Decrease (increase) in biological assets | — | ($1.1m) | ($2.0m) | ($2.4m) | ($799k) | $5.5m | ($4.2m) | $5.0m | — | |
| Disposal (acquisition) of subsidiary, net of cash against share issuance (Note 8) | — | $107.6m | $6.9m | $17.4m | — | — | ($8.1m) | — | — | |
| Additions to right-of-use assets | — | — | — | — | — | $3.0m | $6.7m | $767k | — | |
| Short term loan | — | ($2.1m) | ($1.3m) | ($4.3m) | $4.3m | $4.3m | $198k | $25k | — | |
| Short term loan to related parties | — | ($716k) | — | ($5.1m) | ($2.6m) | ($2.6m) | — | — | — | |
| Issuance of shares | — | ($107.6m) | ($6.9m) | ($17.4m) | ($17.4m) | — | $1.0m | $1.3m | — | |
| Non-controlling interests | — | — | ($15.7m) | $9.0m | ($142k) | ($142k) | $1.9m | $1.1m | — | |
| Contingent consideration | — | — | — | ($18.7m) | $10.2m | $10.2m | $120k | — | — | |
| Deferred consideration | — | — | — | ($9.9m) | $4.4m | $4.4m | — | — | — | |
| Lease liability | — | — | ($2.0m) | ($2.6m) | ($2.6m) | — | ($3.5m) | — | — | |
| Loss (gain) | — | — | — | — | — | — | ($1.3m) | $3.3m | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | $120.4m | ($82.9m) | $26.5m | ($46.7m) | ($46.7m) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | ($142.5m) | $4.8m | $17.7m | ($2.0m) | ($2.0m) | |
| Change In Account Payable | — | — | — | — | $57.0m | ($47.6m) | ($8.9m) | ($8.8m) | ($8.8m) | |
| Change In Payable | — | — | — | — | $56.2m | ($43.0m) | ($5.0m) | ($6.4m) | ($8.8m) | |
| Changes In Cash | — | — | — | — | $29.2m | ($131.7m) | ($22.8m) | ($31.8m) | ($31.8m) | |
| End Cash Position | — | — | — | — | $232.6m | $101.1m | $78.3m | $46.5m | $46.5m | |
| Financing Cash Flow | — | — | — | — | $120.4m |
($82.9m)
-168.82%
|
$26.5m
+131.92%
|
($46.7m)
-276.37%
|
($46.7m)
0.00%
|
|
| Free Cash Flow | — | — | — | — | $31.5m | ($56.2m) | ($71.3m) | $13.3m | $13.3m | |
| Gain Loss On Sale Of Business | — | — | — | — | $0 | $0 | ($1.5m) | $3.3m | $3.3m | |
| Gain Loss On Sale Of PPE | — | — | — | — | $0 | $412k | $394k | $0 | $0 | |
| Interest Received CFI | — | — | — | — | $0 | $845k | $0 | $939k | $939k | |
| Investing Cash Flow | — | — | — | — | ($142.5m) | $4.8m | $17.7m | ($2.0m) | ($2.0m) | |
| Net Business Purchase And Sale | — | — | — | — | ($14.5m) | ($4.2m) | $405k | $1.7m | $1.7m | |
| Net PPE Purchase And Sale | — | — | — | — | ($19.7m) | ($2.6m) | ($4.4m) | ($3.5m) | ($3.5m) | |
| Operating Gains Losses | — | — | — | — | $418k | $228k | ($1.0m) | $3.2m | $3.2m | |
| Other Non Cash Items | — | — | — | — | ($2.8m) | $22.1m | $26.2m | $16.9m | — | |
| Pension And Employee Benefit Expense | — | — | — | — | $418k | ($184k) | $132k | ($92k) | ($92k) | |
| Proceeds From Stock Option Exercised | — | — | — | $8.5m | $0 | $0 | — | — | $2.1m | |
| Purchase Of Business | — | — | — | — | ($16.0m) | ($4.2m) | ($703k) | ($765k) | ($765k) | |
| Purchase Of PPE | — | — | — | $14.0m | ($19.7m) | ($2.6m) | ($4.4m) | ($3.5m) | ($3.5m) | |
| Sale Of Business | — | — | — | — | $1.6m | $0 | $1.1m | $2.4m | $2.4m | |
| Sale Of PPE | — | — | — | — | $0 | $25k | $0 | $0 | $0 | |
| Stock Based Compensation | — | — | — | — | $8.9m | $2.6m | $2.3m | $2.4m | $2.4m | |
| Unrealized Gain Loss On Investment Securities | — | — | — | — | $172k | $661k | ($371k) | $2.1m | $2.1m | |
| Total acquisition of subsidiary, net of cash | — | ($385k) | ($387k) | ($19.1m) | $1.6m | $1.6m | ($1.1m) | $114k | — | |
| Total disposal of subsidiary, net of cash | — | — | — | — | — | — | ($2.5m) | ($2.4m) | — | |
| Net Investment Purchase And Sale | — | — | — | ($1.2m) | $0 | — | — | — | — | |
| Purchase Of Investment | — | — | — | ($1.2m) | $0 | — | — | — | — | |
| Change In Cash Supplemental As Reported | — | — | — | — | $29.2m | ($131.7m) | ($22.8m) | ($31.8m) | — | |
| Interest Paid Classified As Financing Activities | — | ($41k) | ($93k) | ($5.1m) | $17.3m | $20.9m | $15.2m | ($19.0m) | — | |
| Interest Paid Classified As Operating Activities | — | ($41k) | $93k | $5.1m | ($17.3m) | ($20.9m) | ($15.2m) | ($19.0m) | — | |
| Income Taxes Paid Refund Classified As Operating Activities | — | ($50k) | — | $11.8m | $8.0m | $7.6m | $12.9m | $306k | — |